Health and Me on MSN12h
These Are The Five Rare Diseases You Did Not Know Existed
It is always good to know about diseases so you can read the signs your body is telling you. However, there exists many ...
Chip Chick on MSN12d
Stone Man Syndrome Is A Rare Disease That Turns Muscles Into Bones
For patients with a rare genetic disorder that turns their muscles into bone, there is new hope. The disease is […] ...
Their flesh turns to bone, but a new treatment might help them
That is the predicament of patients with fibrodysplasia ossificans progressiva (FOP) or “Stone Man Syndrome”, a rare ...
‘I’m like a mannequin,’ says this rare disease patient
Also known colloquially as “Stone Man Syndrome”, FOP is a rare genetic disorder where, after birth and progressively through ...
Medindia1y
Rare Bone Disease Traced To Faulty FOP Gene
The mystery surrounding a rare bone disease called fibrodysplasia ossificans progressiva (FOP) has been resolved following the identification of a mutant gene linked to the disease. The mystery ...
Nature2y
Landmark study completed for ultra-rare bone-forming disease
Although there are descriptions of FOP dating back to 1740, for centuries the disease remained an enigmatic medical curiosity. FOP’s origins were eventually revealed in 2006. A team of ...
pharmaphorum1y
Ipsen drug is first therapy for rare bone disease FOP in US
With FDA approval, Ipsen's marathon effort to bring palovarotene to market for the rare disease fibrodysplasia ossificans progressiva (FOP) has finally crossed the finish line in the US ...
Green Bay Press-Gazette25d
9-year-old Green Bay fan gets a trip of a lifetime to Brewers spring training
Nine-year-old Natasha Taylor, who lives with a rare bone disease, was gifted a trip to the Milwaukee Brewers spring training. Natasha was diagnosed with fibrodysplasia ossificans progressiva (FOP ...
pharmaphorum8d
After FDA setback, Ipsen gets first OK for rare disease drug palovarotene
It also gives Ipsen first-mover advantage over its main rival in the FOP space, Regeneron, which has had it own problems bringing a drug candidate for the disease to market. Regeneron is ...